House Committee Requests DOJ Review of Group Lobbying Against Chinese Biotech Ban Act

The BIOSECURE Act lists four ‘biotechnology companies of concern,’ for their close ties to the CCP and its military, the PLA.

Chairman of the Select Committee on the Chinese Communist Party (CCP), Rep. Mike Gallagher (R-Wis.), speaks during a press conference unveiling the results of the Committee’s investigation into the biolab discovered in Reedley, Calif., in Washington on Nov. 15, 2023. Madalina Vasiliu/The Epoch Times

The House Select Committee on the Chinese Communist Party (CCP) has asked the Department of Justice to review a D.C.-based trade group that allegedly lobbies on behalf of a CCP-linked biotech company.

In a letter dated March 5 to Attorney General Merrick Garland, Rep. Mike Gallagher (R-Wis.), the committee’s Chairman, raised concerns regarding the Biotechnology Innovation Organization (BIO), a trade association representing the biotechnology industry, and its lobbying effort against the BIOSECURE Act. This legislation aims to prevent federally funded providers from benefiting Chinese biotech firms, including WuXi AppTec.